At the Thirteenth International Kidney Cancer Symposium, Dr Hans Hammers (Johns Hopkins, MD) encourages kidney cancer patients to take an active role in health care. Currently, a strategic and patient-tailored approach is recommended in kidney cancer management. Dr Hammers discusses how clinical trials represent opportunities for patients to access new medicines and further therapy development.
Advertisement Single Below Content
Advertisement Single Below Content
Advertisement Single Below Content